Skip to main content
. 2021 Mar 2;65:103259. doi: 10.1016/j.ebiom.2021.103259

Fig. 2.

Fig 2

Longitudinal antibody responses across all timepoints in participants seropositive at any timepoint

Individual participant data (left) and time ordered aggregate data (right) for Euroimmun anti-S1 antibody assay (N=145) (a–b) and Roche combined anti-NP antibody assay (N=150) (c–d) showing the heterogeneity in antibody responses between individuals and the differences in antibody kinetics between assays, with an earlier peak and decline in anti-S1 compared with anti-NP antibodies.